What must I submit for Part A of the application?
Documents belonging to Part A of the application form should preferably be submitted via the 'berichtenbox' or via a digital information carrier (CD-ROM or USB stick). A folder structure and naming must be maintained as shown in Table 1, where:
- All public documents must be submitted in PDF/A format.
- All other documents must be submitted in PDF format.
- All articles belonging to the application must be submitted in a separate folder called "Artikelen". This folder with scientific articles will not be made public.
- Other public documents, including protocols, guidelines or procedures must be placed in a folder called “Openbaar”.
- All documents that are claimed to be confidential must be clearly marked as confidential and placed in folder called "Vertrouwelijk”.
- Please use ZIP-files in case of large number of appendices.
The following documents must be supplied as hard copy or via the 'berichtenbox':
- Signed cover letter
- General (personal) information
- Optional: mandate Environmental Safety Officer ( ESO environmental safety officer (environmental safety officer ))
In those cases where a signature of the legal entity is requested, a pen-drawn signature on a printed copy of the document is required. Forms that are submitted via the 'berichtenbox' do not have to be signed. The ‘eHerkenning’ of the 'berichtenbox' procedure is sufficient.
Extract NHR and/or mandate ESO
The signing of the legal entity is always verified and therefore the data in the Dutch Business Register (NHR) of your organization must always be up-to-date. On behalf of the legal entity a person must sign who is registered as an authorized signatory in the NHR. On behalf of legal entities a person may also sign who is mandated. The mandate containing the sign authority must be attached. If the 'berichtenbox' is used, the correct authorization is arranged via the ‘eHerkenning’.
Tabel 1. Documents and structure for digital submission
|Application form Part A||PDF/A|
|All public guidelines, protocols and documents (no articles) as separate files||PDF/A|
|Signed cover letter|
|General (personal) information|
|Mandate Environmental Safety Officer ( ESO environmental safety officer (environmental safety officer ))|
|All (scientific) articles as separate files|
|All appendices as separate files that are claimed by the applicant as confidential|
What must I submit for Part B of the application?
The ABR form General Assessment and Registration form (General Assessment and Registration form ) belonging to Part B of the application form must be submitted via the web portal ToetsingOnline, http://www.toetsingonline.nl/. You may include certain data which can be uploaded from the EudraCT European Union Drug Regulating Authorities Clinical Trials (European Union Drug Regulating Authorities Clinical Trials ) form. On the CCMO Central Committee on Research involving Human Subjects (Central Committee on Research involving Human Subjects ) website you will find an example of the ABR form and explanatory notes.
Once you have a final version of the ABR form you must send in a signed version, together with your research file, on a CD-ROM or USB-flash drive in PDF/A format together with a signed cover letter on paper to the CCMO. More information can be found at https://english.ccmo.nl/investigators/standard-research-file and https://english.ccmo.nl/investigators/news/2020/03/19/from-friday-20-march-only-digital-submission.
The Ministry of VWS Ministry of Health, Welfare and Sport (Ministry of Health, Welfare and Sport ) requires digital submission on a CD-ROM, usb flash drive or Eudralink. , which means that the cover letter should be on paper but all remaining documents should be submitted in PDF/A format on a single CD-ROM, coded according to the standard research file (more information is available at https://english.ccmo.nl/investigators/standard-research-file. and https://english.ccmo.nl/investigators/news/2020/03/19/from-friday-20-march-only-digital-submission).
n documentenstroom voor officiële indiening bij Loket Gentherapie.